Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Zelira Therapeutics Limited market cap is $7.81M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zelira Therapeutics Limited 52 week high is $1.65 as of December 11, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zelira Therapeutics Limited 52 week low is $0.55 as of December 11, 2023.
Zelira Therapeutics Limited stock price today is $0.688.
Zelira Therapeutics Limited stock price yesterday was $0.5739.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Zelira Therapeutics Limited’s P/E ratio is -1.85.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Zelira Therapeutics Limited P/B ratio is 0.3688.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Zelira Therapeutics Limited's EBITDA is -2.39.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Zelira Therapeutics Limited 50-day moving average is $0.6156.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.